Key Metrics of Biogen
Revenue$9.8B▼ 3.3% YoYFY 2023
Operating income—
Net profit$1.2B▼ 61.9% YoY
Shareholders' equity$14.8B
Market cap$35.9BBIIB · $243.10
Competitors10identified
About Biogen
Part of Biogen.
Sectors
Company details
- Website
- biogen.com
- Listed
- Nasdaq: BIIB
Operational Areas of Biogen
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameBiogen Inc.
TickerBIIB
ExchangeNasdaq
CountryUnited States
SEC CIK0000875045
Listed since—
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttps://www.biogen.com
US market & SEC filings
BIIB · Nasdaq · SEC CIK 0000875045
Last price · 22 Oct 2026
$243.10
+4.12%
Market cap$35.9B
P/E30.5On FY 2023 diluted EPS
Volume1,492,301
SectorHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Country · IPOUnited States
BIIB share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeCambridge
GSTIN—
Email—
Websitehttps://www.biogen.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Biogen
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Part of Biogen
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.